Elsevier

Transplant Immunology

Volume 24, Issue 1, October 2010, Pages 9-16
Transplant Immunology

The impact of CD4+Foxp3+ Treg on immunity to murine cytomegalovirus after bone marrow transplantation depends on the peripheral or thymic source of T cell regeneration

https://doi.org/10.1016/j.trim.2010.08.003Get rights and content

Abstract

Objective

The adoptive transfer of regulatory T cells (Treg) in murine models has been shown to ameliorate graft-versus-host disease while it may preserve the graft-versus-leukemia effect. However, the impact of Treg on infectious immunity after bone marrow transplantation (BMT) is still unclear. Immunocompetence against opportunistic viral infections depends on the kinetics of T cell recovery after BMT through two distinctive processes, i.e. lymphopenia-induced proliferation (LIP) of mature T cells and generation of T cells through thymopoiesis.

Methods

In this study, we set out to assess the effects of adoptively transferred Treg on T cell regeneration in a homeostatic peripheral T cell expansion model and a thymopoiesis-dependent BMT model, and on murine cytomegalovirus (mCMV) clearance and mortality following mCMV challenge.

Results

Using lymphopenic Rag-2−/−γc−/− mice that received a limited number of congenic T cells, we demonstrate that adoptively transferred Treg abrogate LIP of T cells. mCMV challenge resulted in a rapid increase of viral load and death in mice that received Treg, but not in controls. In contrast, following syngeneic T cell-depleted BMT in Rag-2−/−γc−/− mice, adoptively transferred Treg did not delay T cell reconstitution nor suppressed thymic output and had no effect on viral clearance and survival following mCMV-challenge.

Conclusion

The effect of Treg on T cell-mediated immunocompetence against mCMV early after BMT depends on the relative contribution of peripheral expansion and thymopoiesis to T cell regeneration.

Introduction

Graft-versus-host disease (GVHD) and infectious complications are major factors contributing to morbidity and mortality following allogeneic hematopoietic stem cell transplantation [1], [2]. Since GVHD is mainly caused by donor-derived T cells recognizing genetically disparate host cells, an effective method to prevent GVHD is T cell depletion (TCD) of the graft. However, TCD may also ameliorate the beneficial graft-versus-leukemia (GVL) effect and results in a prolonged period of T cell lymphopenia [3], which is an important risk factor for viral reactivations, disease and treatment-related mortality [4], [5]. The recovery of virus-specific T cells has been shown to be pivotal for the control of cytomegalovirus (CMV)- and Epstein–Barr virus infection and disease [6], [7], [8], [9].

One of the more promising pre-clinical treatment modalities for GVHD is the adoptive transfer of regulatory T cells (Treg) [10], [11]. Treg are essential for the induction and maintenance of peripheral immunological tolerance and are characterized as CD4+CD25+Foxp3+ T cells. In vitro, Treg suppress the activation, proliferation and cytokine secretion of conventional T cells [12]. Accumulating data in several experimental bone marrow transplantation (BMT) models demonstrate the critical role of Treg in dampening GVHD and facilitating engraftment. Depletion of Treg from the graft or in vivo depletion of CD25+ T cells of the recipient before BMT augments GVHD [13], [14], [15]. In contrast, adoptive transfer of Treg at the time of BMT ameliorates GVHD [13], [14], [15], [16] and prevents bone marrow graft rejection [16]. As the suppressive effect of Treg is antigen non-specific [17], concerns have been raised about their possible bystander suppression on GVL and anti-viral immunity after SCT. Murine studies show that adoptive transfer of Treg in host mice with leukemia can ameliorate the development of GVHD while concurrently preserving GVL effects [18], [19], [20]. However, little is known about the impact of adoptively transferred Treg on anti-viral immunity after SCT. Opportunistic human CMV infection remains an important infectious complication following SCT [21], [22] and the murine cytomegalovirus (mCMV) model has served as an excellent model for T-cell mediated immunity [23], [24]. As the anti-viral immunity critically depends on the kinetics of T-cell reconstitution, we assessed the effects of Treg on both sources of T cell regeneration after BMT, i.e. lymphopenia-induced proliferation (LIP) of mature T cells and thymopoiesis. In addition we assessed the effects of Treg on T cell-mediated immunity against murine cytomegalovirus (mCMV). We show that adoptive transfer of CD4+CD25+Foxp3+ Treg suppresses LIP of T cells, while de novo generation of T cells in the thymus after BMT appears unaffected. Consequently, T cell-mediated immunity against mCMV is not altered by Treg when thymopoiesis provides the main source of T cell reconstitution.

Section snippets

Mice

Balb/c mice were purchased from Charles River Laboratory. Rag-2−/− common cytokine gamma chain (γc)−/− mice on a mixed background (provided by Dr. H Spits, Netherlands Cancer Institute, Amsterdam) were inbred on a Balb/c background. Wild-type Balb/c-Thy1.1 mice were provided by Dr. Busch (Munich, Germany). Mice were bred under specific pathogen-free conditions at the Erasmus MC Experimental Animal Centre. Mice were used at 10–12 weeks of age. Food and water were available ad libitum. Housing,

CD4+CD25+Foxp3+ Treg remain suppressive following in vitro expansion and inhibit LIP in a dose-dependent manner

As it was previously shown that CD4+CD25+ Treg, in contrast to CD4+CD25- non-Treg, can inhibit LIP of T cells [27], [28], [29], [30], [31], we first wanted to determine the effect of Treg on LIP of T cells in our model in the absence of mCMV. To generate sufficient number of Treg for adoptive transfer, CD4+CD25high Treg were purified and subsequently expanded using αCD3/αCD28 beads and high concentrations of exogenous IL-2 [32]. After enrichment and expansion, 90% of the cells co-expressed CD4

Discussion

Regulatory T cells are considered candidates for immunotherapy after BMT as they may reduce GVHD while maintaining GVL effects [18], [19], [20]. However, concerns have been raised about their possible bystander effect on infectious immunity after BMT. Infectious immunity correlates with T cell recovery after transplantation [5], [6], [7], [8], which may occur via two independent production routes, i.e. de novo generation of T cells in the thymus and LIP of mature T-cells. To distinguish the

Authorship and disclosures

MB and EJW designed the study, performed the laboratory work, performed the statistical analysis and wrote the paper. BL wrote the paper. JJC designed the study and wrote the paper. EB was the principal investigator and takes primary responsibility for the paper. All authors read and approved the final manuscript. The authors reported no potential conflicts of interest.

Role of the funding source

This work was financially supported by the Landsteiner Foundation for Blood Transfusion Research (grant no. 0221) and by the Dutch Cancer Society “Koningin Wilhelmina Fonds” (grant 2002-2694). The sponsors had no role in the study design, collection/analysis and interpretation of data, in writing the report and the decision to submit the paper for publication.

References (39)

  • M. Boeckh et al.

    How we treat cytomegalovirus in hematopoietic cell transplant recipients

    Blood

    (2009)
  • A.E. Broers et al.

    Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants

    Blood

    (2003)
  • A.E. Broers et al.

    Quantification of newly developed T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles

    Exp Hematol

    (2002)
  • K.E. Earle et al.

    In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation

    Clin Immunol

    (2005)
  • A. Krmpotic et al.

    Pathogenesis of murine cytomegalovirus infection

    Microbes Infect

    (2003)
  • K. Klenovsek et al.

    Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells

    Blood

    (2007)
  • V.H. Nguyen et al.

    The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

    Blood

    (2008)
  • E.A. Copelan

    Hematopoietic stem-cell transplantation

    N Engl J Med

    (2006)
  • D.H. Kim et al.

    Rapid helper T-cell recovery above 200 × 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation

    Bone Marrow Transplant

    (2006)
  • Cited by (5)

    • Chuanminshen violaceum polysaccharides improve the immune responses of foot-and-mouth disease vaccine in mice

      2015, International Journal of Biological Macromolecules
      Citation Excerpt :

      This may be one of the ways in which CVPS promotes immunity. Recent studies have demonstrated that Foxp3, the forkhead/winged helix transcription factor, is crucial for the development and function of CD4+CD25+Treg cells which have a regulatory role in immunologic suppression [61–64]. Blockade or reduction of CD4+CD25+Treg cells enhances both humoral and cellular responses and provides a balanced immunity after vaccination [65,66].

    • The dual role of the X-linked FoxP3 gene in human cancers

      2011, Molecular Oncology
      Citation Excerpt :

      Natural TRegs possess demethylated CpGs at the FoxP3 locus and show stable FoxP3 expression, whereas TGF-β-induced TRegs show methylated CpGs and do not maintain constitutive FoxP3 expression after restimulation in the absence of TGF-β (Baron et al., 2007; Floess et al., 2007; Lal and Bromberg, 2009; Polansky et al., 2008). It has been reported that a fraction of the FoxP3+CD4+ natural TRegs adoptively transferred into lymphopenic mice are converted into FoxP3− T cells (Bruinsma et al., 2010) http://www.ncbi.nlm.nih.gov/pubmed/19174509. Under inflammatory conditions, FoxP3+ TRegs lose FoxP3 expression and thus suppressive function in an IL-6–dependent manner (Lal et al., 2011) IL-6 and TCR signalling induce down-regulation of FoxP3 expression and lead to development of Th17 cells (Maitra et al., 2009) http://www.ncbi.nlm.nih.gov/pubmed/18585065.

    1

    MB and EJW contributed equally to the study.

    View full text